Cargando…

A Pilot Study of Galectin-3, HBME-1, and p27 Triple Immunostaining Pattern for Diagnosis of Indeterminate Thyroid Nodules in Cytology With Correlation to Histology

Indeterminate thyroid nodules form a heterogenous group of lesions that constitute 5% to 30% of thyroid cytology diagnoses. We introduce a triple immunostaining protocol for subtyping. Galectin-3, HBME-1, and p27 triple immunostaining, performed on destained cytology slides and formalin-fixed paraff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Lei, Krausz, Thomas, DeMay, Richard M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2015
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530731/ https://www.ncbi.nlm.nih.gov/pubmed/25221953 http://dx.doi.org/10.1097/PAI.0000000000000106

Ejemplares similares

Combination of galectin-3, CK19 and HBME-1 immunostaining improves the diagnosis of thyroid cancer
por: Arcolia, Vanessa, et al.
Publicado: (2017)

Large needle aspiration biopsy and galectin-3 determination in selected thyroid nodules with indeterminate FNA-cytology
por: Carpi, A, et al.
Publicado: (2006)

Indeterminate Thyroid Nodules: From Cytology to Molecular Testing
por: Vignali, Paola, et al.
Publicado: (2023)

OR27-3 A Novel Risk Stratification System for Thyroid Nodules with Indeterminate Cytology: A Pilot Cohort Study
por: Gomes-Lima, Cristiane, et al.
Publicado: (2019)

OR27-2 Inter-reader Agreement of ATA Sonographic Risk In Thyroid Nodules With Indeterminate Cytology
por: Linares, Maria, et al.
Publicado: (2019)

Q-Elastography in the Presurgical Diagnosis of Thyroid Nodules with Indeterminate Cytology
por: Cantisani, Vito, et al.
Publicado: (2012)

Molecular Variants and Their Risks for Malignancy in Cytologically Indeterminate Thyroid Nodules
por: Goldner, Whitney S., et al.
Publicado: (2019)

Diagnostic Value of Galectin-3, HBME-1, Cytokeratin 19, High Molecular Weight Cytokeratin, Cyclin D1 and p27(kip1) in the Differential Diagnosis of Thyroid Nodules
por: Park, Young Joo, et al.
Publicado: (2007)

Cost-effectiveness analysis of molecular testing for cytologically indeterminate thyroid nodules
por: Dharampal, Navjit, et al.
Publicado: (2022)

A Novel Risk Stratification System for Thyroid Nodules With Indeterminate Cytology—A Pilot Cohort Study
por: Gomes-Lima, Cristiane J., et al.
Publicado: (2020)

Comparison of Afirma GEC and GSC to Nodules Without Molecular Testing in Cytologically Indeterminate Thyroid Nodules
por: Polavarapu, Preethi, et al.
Publicado: (2021)

Galectin-3 Performance in Histologic and Cytologic Assessment of Thyroid Nodules: A Systematic Review and Meta-Analysis
por: Trimboli, Pierpaolo, et al.
Publicado: (2017)

Identification of potential novel biomarkers to differentiate malignant thyroid nodules with cytological indeterminate
por: Wu, Dandan, et al.
Publicado: (2020)

Performance of multigene testing in cytologically indeterminate thyroid nodules and molecular risk stratification
por: Zhou, Yuanyuan, et al.
Publicado: (2023)

BRAF mutation in cytologically indeterminate thyroid nodules: after reclassification of a variant thyroid carcinoma
por: Pongsapich, Warut, et al.
Publicado: (2019)

A Genomic Alternative to Identify Medullary Thyroid Cancer Preoperatively in Thyroid Nodules with Indeterminate Cytology
por: Kloos, Richard T., et al.
Publicado: (2016)

Risk of malignancy in cytologically indeterminate thyroid nodules harboring thyroid stimulating hormone receptor mutations
por: Whitmer, Dorota, et al.
Publicado: (2022)

Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules
por: Rowe, Leslie R, et al.
Publicado: (2006)

Evaluation and Management of Indeterminate Thyroid Nodules: The Revolution of Risk Stratification Beyond Cytological Diagnosis
por: Valderrabano, Pablo, et al.
Publicado: (2017)

The value of routine measurement of serum calcitonin on insufficient, indeterminate, and suspicious thyroid nodule cytology
por: Sencar, Muhammed Erkam, et al.
Publicado: (2022)

An innovative synthetic support for immunocytochemical assessment of cytologically indeterminate (Bethesda III) thyroid nodules
por: Taccogna, Silvia, et al.
Publicado: (2022)

Expression of ck-19, galectin-3 and hbme-1 in the differentiation of thyroid lesions: systematic review and diagnostic meta-analysis
por: de Matos, Leandro Luongo, et al.
Publicado: (2012)

Apropos of quality for fine-needle aspiration cytology of thyroid nodules with 22-, 23-, 25-, even 27-gauge needles and indeterminate cytology in thyroidology: an aide memory
por: Sengul, Ilker, et al.
Publicado: (2022)

Comparison of S-Detect and thyroid imaging reporting and data system classifications in the diagnosis of cytologically indeterminate thyroid nodules
por: Zhou, Ling, et al.
Publicado: (2023)

Pilot imaging study of o-BMVC foci for discrimination of indeterminate cytology in diagnosing fine-needle aspiration of thyroid nodules
por: Tseng, Ting-Yuan, et al.
Publicado: (2021)

The Combined Utility of HBME-1 and Galectin-3 Immunohistochemistry and BRAF V600E Mutations in the Diagnosis of Papillary Thyroid Carcinoma
por: Ramkumar, Subramaniam, et al.
Publicado: (2021)

Analytical Verification Performance of Afirma Genomic Sequencing Classifier in the Diagnosis of Cytologically Indeterminate Thyroid Nodules
por: Hao, Yangyang, et al.
Publicado: (2019)

ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology
por: Barbosa, Thayse Lozovoy Madsen, et al.
Publicado: (2019)

Diagnostic performance of Midkine ratios in fine-needle aspirates for evaluation of Cytologically indeterminate thyroid nodules
por: Zhou, Le, et al.
Publicado: (2021)

Malignancy Risk in RAS-Mutated Cytologically Indeterminate Thyroid Nodules: Real-World Clinical Experience
por: Lu, Joseph, et al.
Publicado: (2021)

Health-related quality of life following FDG-PET/CT for cytological indeterminate thyroid nodules
por: de Koster, Elizabeth J, et al.
Publicado: (2022)

ThyroidPrint®: clinical utility for indeterminate thyroid cytology
por: Olmos, Roberto, et al.
Publicado: (2023)

Indeterminate Thyroid Nodules: When to Worry?
por: Tibbels, Amanda
Publicado: (2023)

Thyroid Fine Needle Aspiration Biopsies in Children: Study of Cytological-Histological Correlation and Immunostaining with Thyroid Peroxidase Monoclonal Antibodies
por: Hoperia, Victoria, et al.
Publicado: (2010)

The Mcgill thyroid nodule score – does it help with indeterminate thyroid nodules?
por: Varshney, Rickul, et al.
Publicado: (2015)

Differential expression of galectin-3, CK19, HBME1, and Ret oncoprotein in the diagnosis of thyroid neoplasms by fine needle aspiration biopsy
por: Saleh, Husain A., et al.
Publicado: (2009)

Galectin-3 and HBME-1 Expression on Agarose Cell Blocks from Fine-needle aspirates of Follicular Cell-derived Thyroid Tumors
por: Abu-Sinna, E., et al.
Publicado: (2018)

Molecular Diagnosis Using Residual Liquid-Based Cytology Materials for Patients with Nondiagnostic or Indeterminate Thyroid Nodules
por: Kwon, Hyemi, et al.
Publicado: (2016)

Clinical validation of the ThyroSeq v3 genomic classifier in thyroid nodules with indeterminate FNA cytology
por: Nikiforov, Yuri E., et al.
Publicado: (2019)

Comparative analysis of diagnostic performance, feasibility and cost of different test-methods for thyroid nodules with indeterminate cytology
por: Sciacchitano, Salvatore, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_si51ppvsvbms8bfh7p4i15k1fg